Clinical Trials Logo

Filter by:
NCT ID: NCT04943627 Withdrawn - Advanced Cancer Clinical Trials

Balstilimab Versus Investigator Choice Chemotherapy in Patients With Recurrent Cervical Cancer (BRAVA)

Start date: August 2, 2021
Phase: Phase 3
Study type: Interventional

This Phase 3 trial is an open-label, randomized study with single-agent Balstilimab (BAL) or Investigator Choice (IC) chemotherapy (single-agent gemcitabine, irinotecan, pemetrexed, vinorelbine, or topotecan) in patients with recurrent, persistent, or metastatic cervical cancer who have progressed after receiving platinum based chemotherapy.

NCT ID: NCT04942340 Withdrawn - Clinical trials for Emergence From Anesthesia

Turning Dexmedetomidine Into a Powerful Anesthetic That Can be Rapidly and Completely Reversed

Start date: May 2023
Phase: Phase 1
Study type: Interventional

In this study, the investigators will explore Atipamezole & caffeine's ability to facilitate the emergence from anesthesia. Each subject will visit UChicago 4 times. The first time for informed consent. The second time for a complete physical exam to ensure that the subjects are healthy. Then there are 2 sedation sessions. Subjects get an honorarium for each sedation session.

NCT ID: NCT04941378 Withdrawn - Ovarian Cancer Clinical Trials

OTL38 Injection (OTL38) for Intra-Operative Imaging of Folate Receptor Positive Ovarian Cancer

Start date: May 28, 2022
Phase: Phase 1
Study type: Interventional

The primary objective of the study is to compare the performance of different camera imaging systems in assessing the positive predictive values and sensitivity of OTL38 to detect folate positive ovarian cancer cancers using the gold standard of pathologic review.

NCT ID: NCT04939987 Withdrawn - Clinical trials for Radical Prostatectomies

Opioid-Free Pain Control Regiment Following Robotic Radical Prostatectomy

Start date: August 2022
Phase: Phase 2/Phase 3
Study type: Interventional

This study will address the gaps in research of non-opioid postoperative pain management for prostatectomies.

NCT ID: NCT04939311 Withdrawn - Inflammation Clinical Trials

Immunomodulation Using VB-201 to Reduce Arterial Inflammation in Treated HIV - VITAL HIV Trial

Start date: July 1, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

This study is a double blinded, placebo-controlled, randomized, parallel group study, designed to compare the efficacy and safety of VB-201 80mg taken orally once daily to placebo for anti-inflammation in HIV-infected subjects.

NCT ID: NCT04939220 Withdrawn - Clinical trials for Cardiopulmonary Disease

SGA for TEE: Safe Alternative to Deep Sedation for Patients With High-risk Cardiopulmonary Disease.

SGA-TEE
Start date: February 2024
Phase: N/A
Study type: Interventional

Increasingly, transesophageal echos (TEEs) are being done on high risk patients. A TEE is a short procedure done with deep sedation, but poses an increased risk of apnea/ hypoxemia in those with pulmonary disease. It is desirable to avoid intubation, which adds risk. Use of supraglottic airway (SGA) may offer an alternative. The investigators hypothesize that TEEs can be done successfully with an SGA in place. The investigators propose a prospective RCT to compare TEE exams done with deep sedation to those done with an SGA.

NCT ID: NCT04938635 Withdrawn - Beta-Thalassemia Clinical Trials

Efficacy and Safety Study of Multiple Doses of VIT-2763 in Adults With Transfusion-dependent Beta-thalassemia

Start date: September 20, 2021
Phase: Phase 2
Study type: Interventional

The main purpose of this study is to evaluate the efficacy of 3 multiple doses of VIT-2763 as measured by the reduction in red blood cell (RBC) transfusion burden from Week 13 to Week 24, to identify the most efficacious and safe dose.

NCT ID: NCT04936425 Withdrawn - Clinical trials for Esophageal Stent Fixation

Comparison of Stent Suturing Versus OTSC Stentfix

Start date: July 21, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate whether OTSC stentfix is a feasible, safe, and efficient device that can be used for esophageal stent fixation (to prevent stent migration) in patients with benign, non-stricture esophageal lesions, including leaks, perforation, and fistulae. Currently, self-expandable metal stents (SEMS) have a risk of migration which can lead to adverse events such as bleeding and perforation. There has been clinical experience demonstrating that stent suturing can prevent stent migration. However, stent suturing can significantly increase endoscopic procedural time. The use of OTSC stentfix for stent fixation is promising as it is likely less time-consuming and less technically difficult, with likely a similar rate of fixation and migration. This non-inferiority study aims to investigate how OTSC stentfix functions as compared to stent suturing. If OTSC stentfix is at least comparable to stent suturing, it can reduce endoscopy procedural times, minimize peri-endoscopic risks, and minimize adverse events related to stent migration.

NCT ID: NCT04933253 Withdrawn - Clinical trials for Blood Loss, Surgical

Mediastinal Temperature and Post-operative Bleeding

Start date: October 2022
Phase: N/A
Study type: Interventional

This study will investigate how chest temperature relates to blood loss and blood clotting. Researchers will use infra-red thermometers to measure the temperature of the chest at the end of surgery see if this relates to the amount of blood collected from the surgical drains. In addition, researchers will test if warm irrigation of the chest increases the temperature of the chest and if this impacts blood loss.

NCT ID: NCT04933240 Withdrawn - Vaginal Bleeding Clinical Trials

Tamoxifen Versus Estradiol for Unscheduled Bleeding in Etonogestrel Implant Users, a Randomized Pilot Trial

Start date: May 2022
Phase: Phase 4
Study type: Interventional

The purpose of this research study is to evaluate the ability of medicines called tamoxifen or estradiol to prevent annoying vaginal bleeding for arm implant users.